| pubmed-article:6813679 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C0005456 | lld:lifeskim |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C0037791 | lld:lifeskim |
| pubmed-article:6813679 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
| pubmed-article:6813679 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:6813679 | pubmed:dateCreated | 1982-12-18 | lld:pubmed |
| pubmed-article:6813679 | pubmed:abstractText | The contribution of the H- and L-chains to the structure of the main idiotype of anti-poly (Glu60-Ala30-Tyr10) (GAT) antibodies has been studied. This idiotype has been previously divided into four types of specificity: (1) the highly conserved idiotypic specificity (h.c. GAT) is expressed by anti-GAT antibodies from the guinea-pig, rat and mice; (2) the public specificity (p. GAT) is expressed in an identical form by all anti-GAT antibodies from all strains of mice tested and by all hybridoma products (HP) with anti-GAT activity; (3) the strain-restricted specificity (s.r. GAT-1) is only expressed by anti-GAT antibodies from strains with Ig-1a, Ig-1c and Ig-1c allotypic markers; and finally (4) the individual specificity i1-GAT defined on HP G5 is also expressed by most of the hybridoma protein with anti-poly (Glu50-Tyr50) (GT) activity. In this paper we show that h.c.GAT, p.GAT and i1-GAT require the interaction of H- and L-chains to be expressed: (1) isolated H- and L-chains from HP G5 did not express these specificities; and (2) recombinant molecules composed of H- and L-chains from HP with anti-GAT activity and an irrelevant myeloma protein (MOPC21) never expressed h.c.GAT, p.GAT and i1-GAT. We next investigated the relationship between the GAT binding site and the p.GAT, h.c.GAT and s.r.GAT-1 idiotypic specificities. GAT and GT were not able to inhibit the binding to s.r.GAT-1 while they inhibit the idiotypic binding to p.GAT and h.c.GAT. A GAT fragment of mol. wt 3000 was also shown to inhibit the binding of p.GAT and h.c.GAT to the appropriate sera. Thus p.GAT and h.c.GAT are very close to the GAT combining site while s.r.GAT-1 represents an idiotypic specificity located outside the GAT binding site. | lld:pubmed |
| pubmed-article:6813679 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6813679 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6813679 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6813679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6813679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6813679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6813679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6813679 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6813679 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6813679 | pubmed:issn | 0161-5890 | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:ThèzeJJ | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:MorganH SHS | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:SomméGG | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:MazieJ CJC | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:MoinierDD | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:LeclercqLL | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:SerraJ RJR | lld:pubmed |
| pubmed-article:6813679 | pubmed:author | pubmed-author:FougerèauMM | lld:pubmed |
| pubmed-article:6813679 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6813679 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:6813679 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6813679 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6813679 | pubmed:pagination | 1011-9 | lld:pubmed |
| pubmed-article:6813679 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:meshHeading | pubmed-meshheading:6813679-... | lld:pubmed |
| pubmed-article:6813679 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6813679 | pubmed:articleTitle | Contribution of the H- and L-chains and of the binding site to the idiotypic specificities of mouse anti-GAT antibodies. | lld:pubmed |
| pubmed-article:6813679 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6813679 | lld:pubmed |
